These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11790660)

  • 1. Protection from pulmonary fibrosis in leukotriene-deficient mice.
    Peters-Golden M; Bailie M; Marshall T; Wilke C; Phan SH; Toews GB; Moore BB
    Am J Respir Crit Care Med; 2002 Jan; 165(2):229-35. PubMed ID: 11790660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice.
    Hirata H; Arima M; Fukushima Y; Sugiyama K; Tokuhisa T; Fukuda T
    Respirology; 2013 May; 18(4):674-81. PubMed ID: 23432979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.
    Manoury B; Nenan S; Leclerc O; Guenon I; Boichot E; Planquois JM; Bertrand CP; Lagente V
    Respir Res; 2005 Jan; 6(1):11. PubMed ID: 15663794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis.
    Nagase T; Uozumi N; Ishii S; Kita Y; Yamamoto H; Ohga E; Ouchi Y; Shimizu T
    Nat Med; 2002 May; 8(5):480-4. PubMed ID: 11984592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
    Gao JM; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor NRF2 protects against pulmonary fibrosis.
    Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
    FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Exp Lung Res; 2010 Jun; 36(5):292-301. PubMed ID: 20497024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis.
    Wiley CD; Brumwell AN; Davis SS; Jackson JR; Valdovinos A; Calhoun C; Alimirah F; Castellanos CA; Ruan R; Wei Y; Chapman HA; Ramanathan A; Campisi J; Jourdan Le Saux C
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31687975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice.
    Kurokawa S; Suda M; Okuda T; Miyake Y; Matsumura Y; Ishimura M; Saito R; Nakamura T
    Pulm Pharmacol Ther; 2010 Oct; 23(5):425-31. PubMed ID: 20457270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice.
    Ichinose F; Zapol WM; Sapirstein A; Ullrich R; Tager AM; Coggins K; Jones R; Bloch KD
    Circ Res; 2001 Apr; 88(8):832-8. PubMed ID: 11325876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling.
    Shim YM; Zhu Z; Zheng T; Lee CG; Homer RJ; Ma B; Elias JA
    J Immunol; 2006 Aug; 177(3):1918-24. PubMed ID: 16849505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
    Pardo A; Ruiz V; Arreola JL; Ramírez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
    Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
    Günther A; Lübke N; Ermert M; Schermuly RT; Weissmann N; Breithecker A; Markart P; Ruppert C; Quanz K; Ermert L; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 2003 Dec; 168(11):1358-65. PubMed ID: 14644925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis.
    Izumo T; Kondo M; Nagai A
    Eur Respir J; 2009 Dec; 34(6):1444-51. PubMed ID: 19460787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
    Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
    Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.